Suchergebnisse - "Sanz, Miguel A"

PubPharm (34)

1

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

enthalten in: Cancer | 2021

von Vives, S. | Martínez-Cuadrón, D. | Bergua Burgues, J. | +31

2

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study

enthalten in: Leukemia | 2020

von Kayser, S. | Rahmé, R. | Martínez-Cuadrón, D. | +20

ErratumIn: Leukemia. 2021 Dec;35(12):3631. - PMID 34785795

3

Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols

enthalten in: European journal of haematology | 2020

von Sobas, M. | Rodriguez-Veiga, R. | Vellenga, E. | +21

4

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

enthalten in: Annals of hematology | 2018

von Martínez-Cuadrón, D. | Boluda, B. | Martínez, P. | +19

ErratumIn: Ann Hematol. 2018 Feb 23;:. - PMID 29473097

5

The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia

enthalten in: British journal of haematology | 2018

von Lange, A. | Lima, A. | Lucena-Araujo, A. | +12

6

Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy

enthalten in: Annals of hematology | 2017

von Abla, O. | Ribeiro, R. | Testi, A. | +17

7

Characteristics and management of primary and other immune thrombocytopenias : Spanish registry study

enthalten in: Hematology (Amsterdam, Netherlands) | 2017

von Palau, J. | Sancho, E. | Herrera, M. | +13

8

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

enthalten in: The New England journal of medicine | 2017

von Stone, R. | Mandrekar, S. | Sanford, B. | +26

CommentIn: N Engl J Med. ;377(19):1901. - PMID 29120132

9

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

enthalten in: The New England journal of medicine | 2017

von Kantarjian, H. | Stein, A. | Gökbuget, N. | +23

CommentIn: Nat Rev Clin Oncol. 2017 May;14 (5):264. - PMID 28322244

10

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen : a report from the EBMT Acute Leukemia Working Party

enthalten in: Journal of hematology & oncology | 2017

von Rubio, M. | D'Aveni-Piney, M. | Labopin, M. | +14